Loading...
Biomarkers and Surrogate Endpoints In Clinical Trials
One of the most important considerations in designing clinical trials is the choice of outcome measures. These outcome measures could be clinically meaningful endpoints that are direct measures of how patients feel, function and survive. Alternatively, indirect measures, such as biomarkers that incl...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3551627/ https://ncbi.nlm.nih.gov/pubmed/22711298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.5403 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|